Literature DB >> 17971608

Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?

Isabelle Soerjomataram, Jan Willem Coebergh, Marieke W J Louwman, Otto Visser, Flora E van Leeuwen.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17971608     DOI: 10.1200/JCO.2007.13.7281

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

2.  The decline in breast cancer incidence: real or imaginary?

Authors:  Allison W Kurian; Christina A Clarke; Robert W Carlson
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

3.  [Preclinical studies on the influence of the tyrosine kinase inhibitor AEE788 on malignant properties of renal cell carcinoma cells].

Authors:  S A Wedel; A Mickuckyte; E Juengel; J Jones; L Hudak; D Jonas; R A Blaheta
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

4.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study.

Authors:  Melina Arnold; Nirmala Pandeya; Graham Byrnes; Prof Andrew G Renehan; Gretchen A Stevens; Prof Majid Ezzati; Jacques Ferlay; J Jaime Miranda; Isabelle Romieu; Rajesh Dikshit; David Forman; Isabelle Soerjomataram
Journal:  Lancet Oncol       Date:  2014-11-26       Impact factor: 41.316

5.  Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.

Authors:  Philippe Autier; Magali Boniol; Alice Koechlin; Cécile Pizot; Mathieu Boniol
Journal:  BMJ       Date:  2017-12-05

6.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

7.  Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.

Authors:  Daniël J van der Meer; Iris Kramer; Marissa C van Maaren; Paul J van Diest; Sabine C Linn; John H Maduro; Luc J A Strobbe; Sabine Siesling; Marjanka K Schmidt; Adri C Voogd
Journal:  Int J Cancer       Date:  2020-12-16       Impact factor: 7.396

8.  Recent changes in breast cancer incidence in Spain, 1980-2004.

Authors:  Marina Pollán; Roberto Pastor-Barriuso; Eva Ardanaz; Marcial Argüelles; Carmen Martos; Jaume Galcerán; María-José Sánchez-Pérez; María-Dolores Chirlaque; Nerea Larrañaga; Ruth Martínez-Cobo; María-Cres Tobalina; Enrique Vidal; Rafael Marcos-Gragera; Antonio Mateos; Isabel Garau; María-Dolores Rojas-Martín; Rosario Jiménez; Ana Torrella-Ramos; Josefina Perucha; Maria-Eugenia Pérez-de-Rada; Susana González; María-José Rabanaque; Joan Borràs; Carmen Navarro; Esther Hernández; Angel Izquierdo; Gonzalo López-Abente; Carmen Martínez
Journal:  J Natl Cancer Inst       Date:  2009-10-26       Impact factor: 13.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.